(Q35535393)

8 August 2017

title

Early asthma control and maintenance with eformoterol following reduction of inhaled corticosteroid dose (English)

1 reference

8 August 2017

1 reference

D Price

1

1 reference

8 August 2017

D Dutchman

2

1 reference

8 August 2017

A Mawson

3

1 reference

8 August 2017

B Bodalia

4

1 reference

8 August 2017

S Duggan

5

1 reference

8 August 2017

P Todd

6

1 reference

8 August 2017

FLOW (Eformoterol in the management of mild astmha--eformoterol Turboinhaler with budesonide Turbohaler) research group

7

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

8 August 2017

1 reference

8 August 2017

volume

57

1 reference

8 August 2017

issue

9

1 reference

8 August 2017

page(s)

791-798

1 reference

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group

8 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1746437

Why are long-acting beta-adrenoceptor agonists long-acting?

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1746437

Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1746437

Determining a minimal important change in a disease-specific Quality of Life Questionnaire

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1746437

Oxis (formoterol given by Turbuhaler) showed as rapid an onset of action as salbutamol given by a pMDI

26 September 2018

1 reference

12 December 2020

Guidelines on the management of asthma. Statement by the British Thoracic Society, the Brit. Paediatric Association, the Research Unit of the Royal College of Physicians of London, the King's Fund Centre, the National Asthma Campaign, the Royal Colle

1 reference

12 December 2020

Onset of action of eformoterol by dry powder inhaler: objective and subjective measures

1 reference

12 December 2020

Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of action

1 reference

12 December 2020

Inhaled dry-powder formoterol and salmeterol in asthmatic patients: onset of action, duration of effect and potency

1 reference

12 December 2020

Onset and duration of action of single doses of formoterol inhaled via Turbuhaler

1 reference

12 December 2020

Identifiers

DOI

10.1136/THORAX.57.9.791

1 reference

8 August 2017

1 reference

8 August 2017

1 reference